amiodarone has been researched along with lidocaine in 227 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 66 (29.07) | 18.7374 |
| 1990's | 31 (13.66) | 18.2507 |
| 2000's | 46 (20.26) | 29.6817 |
| 2010's | 60 (26.43) | 24.3611 |
| 2020's | 24 (10.57) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
| Budriesi, R; Chiarini, A; Ioan, P; Sparatore, F; Tasso, B; Terranova, E; Ugenti, MP; Vazzana, I | 1 |
| Abraham, S; Barrett, TD; Beatch, GN; Clohs, L; Dong, Y; Fedida, D; Jung, GL; Liu, Y; Lynn, L; Plouvier, B; Sheng, T; Walker, MJ; Wall, RA; Wang, WQ; Zhu, JJ; Zolotoy, A | 1 |
| Bleich, S; Gulbins, E; Kornhuber, J; Reichel, M; Terfloth, L; Tripal, P; Wiltfang, J | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Budriesi, R; Chiarini, A; Ioan, P; Micucci, M; Novelli, F; Sparatore, A; Sparatore, F; Tasso, B; Tonelli, M; Vazzana, I | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Glen, RC; Lowe, R; Mitchell, JB | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Sen, S; Sinha, N | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Bruno, C; Budriesi, R; Carbonara, R; Carocci, A; Catalano, A; Colabufo, NA; Conte Camerino, D; De Palma, A; Desaphy, JF; Di Mola, A; Franchini, C; Ghelardini, C; Lentini, G; Perrone, MG | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Jewitt, DE | 1 |
| Theisen, K | 1 |
| Coumel, P; Krikler, D; Rosen, MR; Wellens, HJ; Zipes, DP | 1 |
| Basiez, M; Labrid, C; Leinot, M; Talvard, J | 1 |
| Anderson, JL; Harrison, DC; Meffin, PJ; Winkle, RA | 1 |
| Troup, PJ; Zipes, DP | 1 |
| Elizari, MV; Girotti, AL; Halpern, MS; Rosenbaum, MB | 1 |
| Li, JY; Northover, BJ | 1 |
| Honjo, H; Iwata, H; Kamiya, K; Kodama, I; Osaka, T; Toyama, J | 1 |
| Chamberlain, D; von Planta, M | 1 |
| Honjo, H; Kamiya, K; Kodama, I; Toyama, J | 1 |
| Rabkin, SW | 1 |
| Liu, J; Liu, XZ; Zhang, JF | 1 |
| Lin, SO; Su, MJ; Tseng, CD; Tseng, YZ; Wang, CH | 1 |
| Biagetti, MO; de Forteza, E; Quinteiro, RA | 1 |
| Campbell, TJ; Hemsworth, PD; Wyse, KR | 1 |
| Campbell, TJ; Hemsworth, PD | 1 |
| Leffler, J; Lüderitz, B; Nitsch, J | 1 |
| Finch, N; Kratz, J; Leman, RB; Stewart, D | 1 |
| Roden, DM | 1 |
| Grauer, K; Gums, J; Skluth, H | 1 |
| Aomine, M | 1 |
| Chinaglia, A; Cibinel, GA; Mangiardi, L; Uslenghi, E | 1 |
| Chen, HZ; Chen, WZ; Gong, ZX; Guo, Q; Jin, PY; Pen, BZ; Shen, JY; Yang, XY; Yang, YZ | 1 |
| Yamaguchi, I | 1 |
| Somberg, J | 1 |
| Roden, DM; Siddoway, LA; Woosley, RL | 1 |
| Roy, D | 1 |
| Chen, JR; Chen, WZ; Guo, Q; Jin, PY; Yang, XY; Yang, YZ | 1 |
| Echt, DS; Roden, DM; Woosley, RL | 1 |
| Andersson, KE; Wettrell, G | 1 |
| Morganroth, J; Nestico, PF | 2 |
| Huang, SK; Marcus, FI | 1 |
| Light, RT; Onrot, J; Robertson, D; Robertson, RM; Tantengco, MV | 1 |
| Horowitz, LN; Morganroth, J | 1 |
| Hammill, SC; Kreeger, RW | 1 |
| Balducelli, M; Boriani, G; Capucci, A; Magnani, B | 1 |
| Schwartz, PJ; Vanoli, E | 1 |
| Podrid, PJ | 1 |
| Fukuzaki, H; Itoh, S; Kobayashi, K | 1 |
| Agmon, J; Arditti, A; Kusniec, J; Lewin, RF; Sclarovsky, S; Strasberg, B | 1 |
| Schwartz, PJ; Vanoli, E; Zaza, A; Zuanetti, G | 1 |
| Baerman, JM; DiCarlo, LA; Krol, RB; Morady, F | 1 |
| Capucci, A; Magnani, B; Mantovani, B; Maresta, A; Melandri, G | 1 |
| DiGregorio, GJ; Fruncillo, RJ; Kozin, SH | 1 |
| Sanna, GP | 1 |
| Opie, LH | 1 |
| Attuel, P; Coumel, P; Georgiopoulos, G; Halkidis, H; Leclercq, JF; Maisonblanche, P | 1 |
| Reid, PR; Vlay, SC | 1 |
| Hillis, WS; Whiting, B | 1 |
| Prystowsky, EN | 1 |
| Somberg, JC | 1 |
| Doherty, JU; Josephson, ME; Kienzle, MG; Williams, PD; Zygmont, D | 1 |
| Jahrmärker, H; Theisen, K | 1 |
| Duff, HJ; Oates, JA; Roden, DM; Woosley, RL | 1 |
| Mohiuddin, SM; Ross, WB | 1 |
| Lüderitz, B | 1 |
| Pollak, S; Walter, PF | 1 |
| Motté, G | 1 |
| Hess, DS; Scheinman, MM | 1 |
| Rosen, MR; Wit, AL | 1 |
| Block, PJ; Winkle, RA | 1 |
| Hertzberger, DH; Nauta, IL; Rensing, JB; Ruland, CM | 1 |
| Rossi, L | 1 |
| Harrison, DC; Mead, RH | 1 |
| Bettini, R; Dal Forno, P; Disertori, M; Furlanello, F; Gramegna, L; Inama, G; Vergara, G | 1 |
| Kates, RE | 1 |
| Heger, JJ; Prystowsky, EN; Zipes, DP | 1 |
| Luck, JC; Mann, DE; Pratt, CM; Wyndham, CR | 1 |
| Cho, YW; Kuemmerle, HP; Singh, BN | 1 |
| Nademanee, K; Singh, BN | 1 |
| D'Arcy, PF | 1 |
| Zeng, GY | 1 |
| Lukoshevichiute, AI; Reĭngardene, DI | 1 |
| Grenadier, E; Keidar, S; Palant, A | 1 |
| Campbell, RW | 1 |
| Dreifus, LS; Kaplinsky, E; Kmetzo, JJ; Michelson, EL; Naito, M | 1 |
| Carlsson, B; Drvota, V; Häggblad, J; Sylvén, C | 1 |
| Beleslin, BB; Dekleva, MN | 1 |
| Imhoff, TE; Siegmund, JB; Wilson, JH | 1 |
| Gutiérrez-Larraya, F; Jabón, A | 1 |
| Bellone, P; Spirito, P; Vecchio, C | 1 |
| Fulgencio, JP; Hamza, J | 1 |
| Anastasiou-Nana, MI; Moulopoulos, SD; Nanas, JN; Nanas, SN; Poyadjis, A; Rapti, A; Stathaki, S | 1 |
| Beaudoin, D; Matthews, C; Nattel, S; Roy, D; Talajic, M | 1 |
| Hayashi, Y; Kamibayashi, T; Kawabata, K; Sumikawa, K; Takada, K; Yamatodani, A; Yoshiya, I | 1 |
| Chatelain, P; Finance, O; Manning, A | 1 |
| Bruyninckx, C; Chatelain, P; Manning, AS; Ramboux, J | 1 |
| Kowey, PR | 1 |
| Candinas, R; Follath, F; Ha, HR; Meyer, UA; Stieger, B | 1 |
| Dorian, P | 1 |
| Matsumori, A; Nishio, R; Nose, Y; Ono, K; Sasayama, S | 1 |
| Jacobsen, EA; Mortensen, E; Pedersen, HK; Refsum, H | 1 |
| Galenko-Iaroshevskiĭ, PA; Khankoeva, AI; Kryzhanovskiĭ, SA; Popov, PB; Turovaia, AIu; Uvarov, AV | 1 |
| Bartashevich, VV; Boldin, VB; Galenko-Iaroshevskiĭ, PA; Khankoeva, AI; Popov, PB; Sirotenko, DV; Uvarov, AV | 1 |
| Olshansky, B | 1 |
| Kudenchuk, PJ | 1 |
| Barr, A; Cass, D; Cooper, R; Dorian, P; Gelaznikas, R; Schwartz, B | 1 |
| Singh, BN | 1 |
| Pettilä, V; Silfvast, T | 1 |
| Ballew, KA; Philbrick, JT | 1 |
| Tomkiewicz, W | 1 |
| Langes, K; Meininghaus, DG; Spehn, J | 1 |
| Bailin, SJ; Bridges, D; Haffajee, CI; Kerin, NZ; Molnar, J; Paladino, WP; Somberg, JC; Timar, S | 1 |
| Akalin, H; Aral, A; Eren, NT; Eyileten, ZB; Kiziltepe, U; Sirlak, M; Tasoz, R; Uysalel, A | 1 |
| Dorian, P; Sarkozy, A | 1 |
| Kern, KB; Xavier, LC | 1 |
| Kanmatsuse, K; Kasamaki, Y; Kofune, T; Masaki, R; Ohkubo, K; Okumura, Y; Oshikawa, N; Ozawa, Y; Saito, S; Watanabe, I; Yamada, T | 1 |
| Ebrahimi, R; El-Bialy, A; Srivatsa, UN; Wachsner, RY | 1 |
| Brandts, B; Trappe, HJ; Weismueller, P | 1 |
| Chi, CS; Fu, YC; Jan, SL; Wang, JD | 1 |
| Breithardt, G; Reinecke, H | 1 |
| Datta, S; Glusman, S; Torres, M; Waghray, T | 1 |
| Baker, J; Chauhan, V; Damle, R; Fain, E; Mazuz, M; O'Neill, PG; Ross, T; Sharma, AD; Skadsen, A; Zhang, Z | 1 |
| Rosenthal, E; Sivasubramonian, S | 1 |
| Bailin, SJ; Borbola, J; Bridges, DE; Haffajee, CI; Kerin, NZ; Lakatos, F; Molnar, J; Paladino, WP; Sarosi, I; Somberg, JC; Tarjan, J; Timar, S | 1 |
| Basvaraj, S; Dubey, B; Kumar, M; Kumar, R; Lakhotia, R; Mohanty, S | 1 |
| Alexander, KS; Fink, JM; Honisko, ME; Mauro, VF; Militello, MA | 1 |
| Lessa, MA; Tibiriçá, E | 1 |
| Li, Y; Liu, N; Pu, J; Ruan, Y; Wang, L; You, B; Yu, R | 1 |
| Henderson, SO; Idrees, U; Kane-Gill, SL; Kirisci, L; Ou, NN; Oyen, LJ; Rea, RS; Rudis, MI; Seybert, AL; Stauss, JL | 1 |
| Arakaki, T; Isomoto, S; Kawakami, A; Ono, K; Yamashita, S; Yano, K | 1 |
| Al Raisi, M; Lang, E | 1 |
| Menegazzi, JJ; Reynolds, JC; Rittenberger, JC | 1 |
| Hollek, A; Loskot, M; Markiewicz-Łoskot, G; Moric-Janiszewska, E; Szydłowski, L; Weglarz, L | 1 |
| Furukawa, T; Hachiya, H; Higuchi, K; Hirao, K; Isobe, M; Kawabata, M; Okada, H; Sasaki, T | 1 |
| Antzelevitch, C; Belardinelli, L; Burashnikov, A; Di Diego, JM; Zygmunt, AC | 1 |
| Trappe, HJ | 1 |
| Dunning, J; Leeuwenburgh, BP; Maas, JJ; Versteegh, MI | 1 |
| Bryant, SM; Kalimullah, EA | 1 |
| Abe, A; Ikeda, T; Ishiguro, H; Mera, H; Miwa, Y; Miyakoshi, M; Shimizu, H; Tsukada, T; Yoshino, H; Yusu, S | 1 |
| Ayoub, CM; Azar, M; Bou-Khalil, P; El-Khatib, MF; Haddadin, AS; Harfouch, D; Nasr, VG; Sfeir, PM | 1 |
| Mizuno, J; Morita, S; Morita, Y; Yoshimura, T | 1 |
| Harada, M; Honjo, H; Ishiguro, YS; Kamiya, K; Kodama, I; Nakagawa, H; Okuno, Y; Sakuma, I; Takanari, H; Yamazaki, M | 1 |
| Alexander, JH; Ardissino, D; Califf, RM; Granger, CB; Mehta, RH; Ohman, EM; Piccini, JP; Pieper, KS; Schulte, PJ; Van de Werf, F; White, HD | 1 |
| Auer, J; Lamm, G | 1 |
| Browning, K; Lang, ES | 1 |
| Boyd, T; Brady, W | 1 |
| Camporesi, EM; Mangar, D; Mizzi, A; Tran, T | 1 |
| Anderson, JL; Bair, TL; Bunch, TJ; Crandall, BG; Day, JD; Lappe, DL; Mader, KM; Mahapatra, S; May, HT; Molden, J; Muhlestein, JB; Murdock, D; Osborn, JS; Weiss, JP | 1 |
| Montenegro, LM; Naim, M; Nathan, AT; Vetter, VL | 1 |
| Ding, AW; Duan, JA; Lü, GH; Lu, WJ; Ma, HY; You, FQ; Zhou, J | 1 |
| Abel, MD; Barbara, DW; Li, Z; Mauermann, WJ; Meade, LA; Pulido, JN; Schaff, HV; White, RD | 1 |
| Bhavnani, SP; Clyne, CA | 1 |
| Niemann, JT; Rosborough, JP; Shah, AP; Thomas, JL; Youngquist, ST | 1 |
| Griffith, BP; Li, T; Sanchez, PG; Watkins, AC; Wei, X; Wu, ZJ | 1 |
| Berg, MD; Berg, RA; Donoghue, AJ; Hammond, R; Hoyme, DB; Samson, RA; Valdes, SO | 1 |
| Aufderheide, T; Brown, SP; Colella, MR; Daya, M; Dorian, P; Egan, D; Gamber, M; Grunau, BE; Kudenchuk, PJ; Larsen, J; Leroux, B; Morrison, LJ; Powell, J; Rea, T; Stephens, SW; Vaillancourt, C; Wittwer, L | 1 |
| Ikeda, U; Miura, T; Motoki, H; Okada, A; Takeuchi, T; Tomita, T; Yoshie, K | 1 |
| Iannone, P | 1 |
| Brown, SP; Daya, M; Dorian, P; Kudenchuk, PJ; Leroux, B; Morrison, LJ; Powell, J | 1 |
| Arslan, ZI; Ata, Y; Aydin, U; Balcı, C; Kocogullari, CU; Turk, T; Yilmaz, M | 1 |
| Alhumayyd, MS; Almotrefi, AA; Bukhari, IA | 1 |
| Joglar, JA; Page, RL | 1 |
| Aufderheide, TP; Brienza, AM; Brown, SP; Callaway, CW; Christenson, J; Colella, MR; Daya, M; Desvigne-Nickens, P; Dorian, P; Dunford, JV; Egan, D; Gray, PC; Gray, R; Idris, AH; Kudenchuk, PJ; Leroux, B; Morrison, LJ; Nichol, G; Ornato, JP; Rea, T; Seals, N; Stiell, IG; Straight, R; Vaillancourt, C; Vilke, GM; Weisfeldt, ML; Wittwer, L | 1 |
| Marceau, F; Parks, A | 1 |
| Mumma, BE; Umarov, T | 1 |
| Arcadipane, A; Corredor, C; Panarello, G; Pellis, T; Ristagno, G; Sanfilippo, F; Santonocito, C | 1 |
| Daya, M; Dorian, P; Kudenchuk, PJ | 1 |
| Pollak, PT; Spence, JD | 1 |
| Patel, JJ | 1 |
| Fushimi, K; Ishinokami, S; Kaneko, J; Kuno, M; Matsui, H; Tagami, T; Tanaka, C; Unemoto, K; Yasunaga, H | 1 |
| Koyfman, A; Long, B | 1 |
| Chang, WT; Chen, WJ; Chiang, CY; Chuang, PY; Huang, CH; Ma, MH; Tang, CH; Tsai, MS; Wang, TD; Yu, PH | 1 |
| Hunter, BR; Musey, PI | 1 |
| Beyer, A; Ganti, B; Majkrzak, A; Theyyunni, N | 1 |
| Atkins, DL; De Caen, AR; Lopez-Herce, J; Marino, BS; McBride, ME; Webster, G; Ziegler, CP | 1 |
| Tagami, T; Yasunaga, H; Yokota, H | 1 |
| Brignardello-Petersen, R; Cheskes, S; Guyatt, G; Iansavichene, A; McLeod, SL; Worster, A; You, J | 1 |
| Soar, J | 1 |
| Santangeli, P | 1 |
| Aufderheide, TP; Buick, JE; Cheskes, S; Grunau, B; Herren, H; Kime, N; Koller, AC; Menegazzi, JJ; Nuttall, J; Salcido, DD; Schmicker, RH; Sundermann, ML; Zellner, S; Zive, D | 1 |
| Ali, MU; Atkins, DL; Fitzpatrick-Lewis, D; Kenny, M; Nolan, J; Raina, P; Ristagno, G; Sherifali, D; Soar, J | 1 |
| Andersen, LW; Berg, KM; Donnino, MW; Grossestreuer, AV; Moskowitz, A; Ross, CE | 1 |
| Bossaert, L; Böttiger, BW; Deakin, CD; Greif, R; Lockey, A; Lott, C; Maconochie, I; Monsieurs, KG; Nolan, JP; Olasveengen, TM; Perkins, GD; Sandroni, C; Semeraro, F; Soar, J; Van de Voorde, P; Wyllie, J | 1 |
| Berg, KM; Cabañas, JG; Chan, PS; Del Rios, M; Donnino, MW; Hazinski, MF; Hirsch, KG; Kudenchuk, PJ; Kurz, MC; Link, MS; Morley, PT; Panchal, AR | 1 |
| Aickin, R; Andersen, LW; Atkins, DL; Berg, KM; Bingham, R; Böttiger, BW; Callaway, CW; Couper, K; Couto, TB; de Caen, AR; Deakin, CD; Donnino, MW; Drennan, IR; Guerguerian, AM; Hazinski, MF; Lavonas, EJ; Maconochie, I; Meaney, PA; Morley, PT; Nadkarni, VM; Neumar, RW; Ng, KC; Nicholson, TC; Nolan, JP; Nuthall, GA; O'Neil, BJ; Ohshimo, S; Ong, GY; Paiva, EF; Parr, MJ; Reis, AG; Reynolds, JC; Ristagno, G; Sandroni, C; Schexnayder, SM; Scholefield, BR; Shimizu, N; Soar, J; Tijssen, JA; Van de Voorde, P; Wang, TL; Welsford, M | 1 |
| Atkins, DL; Berg, MD; Chan, M; Duff, JP; Haskell, SE; Hazinski, MF; Joyner, BL; Lasa, JJ; Ley, SJ; Raymond, TT; Sutton, RM; Topjian, A | 1 |
| Chang, WT; Chen, WJ; Huang, CH; Liu, YB; Tsai, MS; Wang, CH; Wu, YW; Yu, PH | 1 |
| Barbic, D; Christenson, J; Daya, MR; Dorian, P; Herdeman, C; Idris, A; Kudenchuk, PJ; Leroux, BG; Lupton, JR; Menegazzi, JJ; Mody, P; Morrison, LJ; Newgard, CD; Ornato, JP; Rea, TD; Sopko, G; Vilke, GM | 1 |
| Andersen, LW; Atkins, DL; Donnino, MW; Holmberg, MJ; Ross, CE; Valdes, SO | 1 |
| DeCaen, A; Tijssen, J | 1 |
| Arias, MA; Loughlin, G; Pachón, M | 1 |
| Fajfer, Z; Filipiak, KJ; Jaguszewski, M; Ludwin, K; Nadolny, K; Smereka, J; Szarpak, A; Szarpak, Ł; Ładny, JR | 1 |
| Fan, K; Feng, G; Zhao, H | 2 |
| Allen, R; deSouza, IS; Thode, HC | 1 |
| Gasecka, A; Gilis-Malinowska, N; Jaguszewski, MJ; John, I; Meyer-Szary, J; Peacock, FW; Szarpak, L | 1 |
| Bosley, E; Doan, TN; Rashford, S; Schultz, BV; Wilson, D; Wissa, J | 1 |
| Aleksandrowicz, D | 1 |
| Christenson, J; Davis, D; Daya, MR; Dorian, P; Grunau, B; Kudenchuk, P; Lane, DJ; Lupton, J; Okubo, M; Rea, T; Scheuermeyer, F; Vaillancourt, C; Wang, HE; Yannopoulos, D | 1 |
| Cheskes, S; Dorian, P; Lebovic, G; Lin, S; Rahimi, M | 2 |
| Bobrow, B; Chan, HK; Chavez, S; Gordon, R; Huebinger, R; Jarvis, J; Schulz, K | 1 |
| Chan, HK; Cooper, B; Giordano, J; Harvin, JA; Huebinger, R; Idris, A; Wang, HE | 1 |
| Bradley, SM; Cranford, JA; Kronick, SL; Nawer, H; Neumar, RW; Wagner, D | 1 |
| Amagasa, S; Fukushima, F; Kashiura, M; Kishihara, Y; Moriya, T; Yasuda, H | 1 |
| Daya, MR; Jui, J; Lupton, JR; Neth, MR; Newgard, CD; Sahni, R; Wittwer, L | 1 |
| Chollet-Xemard, C; Ecollan, P; Elie, C; Jouffroy, R; Prunet, B; Treluyer, JM; Vivien, B | 1 |
| Chen, H; Lin, Z; Pan, B; Wang, Q | 1 |
| Kadir, S; Murphy, TW | 1 |
| Bracy, CL; Gupta, R; Hockstein, MA; Hockstein, MJ; Kobres, PY; Lam, PH; Rao, SD; Sheikh, FH | 1 |
49 review(s) available for amiodarone and lidocaine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Limitations of present drug therapy of cardiac arrhythmias--a review.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Humans; Lidocaine; Procainamide; Quinidine; Verapamil | 1977 |
Effects of amiodarone and bepridil on ventricular depolarization and repolarization.
Topics: Amiodarone; Animals; Bepridil; Electrocardiography; Heart Conduction System; Lidocaine; Membrane Potentials; Sodium Channels | 1992 |
Ventricular arrhythmias. An assessment of newer therapeutic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Flecainide; Humans; Lidocaine; Mexiletine; Tocainide; United States | 1989 |
[The interaction of antiarrhythmic drugs with other drugs].
Topics: Adrenergic beta-Agonists; Amiodarone; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Digoxin; Drug Interactions; Humans; Lidocaine; Mexiletine; Phenytoin; Procainamide; Quinidine | 1985 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Clinical pharmacology of old and new antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Benzeneacetamides; Biological Availability; Bretylium Compounds; Disopyramide; Encainide; Flecainide; Humans; Imipramine; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Tocainide | 1985 |
Antiarrhythmic drugs.
Topics: Action Potentials; Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium Channel Blockers; Cell Membrane; Disopyramide; Electrophysiology; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Quinidine; Tocainide | 1986 |
Effects of congestive heart failure on the pharmacokinetics and pharmacodynamics of antiarrhythmic agents.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Digitalis; Disopyramide; Drug Interactions; Encainide; Flecainide; Half-Life; Heart Failure; Hemodynamics; Humans; Kidney; Kinetics; Lidocaine; Liver; Piperidines; Plants, Medicinal; Plants, Toxic; Potassium; Procainamide; Quinidine; Regional Blood Flow; Tocainide | 1986 |
Cardiovascular drugs. I: Antidysrhythmic drugs.
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Cardiovascular Agents; Disopyramide; Drug Interactions; Humans; Kinetics; Lidocaine; Mexiletine; Phenytoin; Procainamide; Tocainide; Verapamil | 1986 |
Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
Topics: Aged; Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Digoxin; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Propranolol; Quinidine; Tocainide; Verapamil | 1986 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil | 1986 |
Antiarrhythmic agents for chronic ventricular arrhythmias.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Procainamide; Propranolol; Quinidine; Tocainide | 1987 |
New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone.
Topics: Administration, Oral; Amiodarone; Anilides; Anti-Arrhythmia Agents; Drug Interactions; Encainide; Flecainide; Heart Conduction System; Humans; Lidocaine; Mexiletine; Tachycardia; Tocainide | 1987 |
Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Propafenone; Propiophenones; Tocainide | 1985 |
Pharmacologic therapy of tachyarrhythmias in patients with Wolff-Parkinson-White syndrome.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Ajmaline; Amiodarone; Anilides; Aprindine; Atrial Fibrillation; Benzofurans; Digitalis Glycosides; Disopyramide; Encainide; Female; Humans; Lidocaine; Male; Middle Aged; Procainamide; Quinidine; Tachycardia; Verapamil; Wolff-Parkinson-White Syndrome | 1983 |
Antiarrhythmic drug therapy for sustained ventricular tachycardia.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bethanidine; Calcium Channel Blockers; Disopyramide; Drug Therapy, Combination; Electrocardiography; Electrophysiology; Encainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Phenytoin; Piperidines; Procainamide; Quinidine; Tachycardia; Tocainide | 1984 |
[Medical treatment of extrasystole and tachycardia (author's transl)].
Topics: Action Potentials; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium; Cardiac Complexes, Premature; Digoxin; Disopyramide; Electrophysiology; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Quinidine; Tachycardia; Tachycardia, Paroxysmal; Verapamil | 1980 |
New antiarrhythmic drugs.
Topics: Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Blood Circulation; Bradycardia; Diltiazem; Half-Life; Humans; Hypertension; Lidocaine; Metoprolol; Nadolol; Nifedipine; Propanolamines; Propranolol; Tocainide; Verapamil | 1983 |
Electropharmacology of antiarrhythmic drugs.
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Electric Conductivity; Heart Atria; Heart Ventricles; Humans; Lidocaine; Membrane Potentials; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Procainamide; Propranolol; Purkinje Fibers; Quinidine; Tocainide; Verapamil | 1983 |
Hemodynamic effects of antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Bretylium Compounds; Calcium Channel Blockers; Disopyramide; Dose-Response Relationship, Drug; Encainide; Flecainide; Hemodynamics; Humans; Lidocaine; Mexiletine; Myocardial Contraction; Phenytoin; Piperidines; Procainamide; Quinidine; Tocainide | 1983 |
Therapy with investigational antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Tocainide | 1984 |
Metabolites of cardiac antiarrhythmic drugs: their clinical role.
Topics: Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Disopyramide; Encainide; Humans; Lidocaine; Piperidines; Procainamide; Quinidine | 1984 |
Investigational antiarrhythmic drugs for the treatment of ventricular rhythm disturbances.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Encainide; Flecainide; Humans; Imipramine; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Tocainide | 1984 |
[Value of drug tests in Wolff-Parkinson-White syndrome].
Topics: Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Atrioventricular Node; Diagnosis, Differential; Electrocardiography; Humans; Lidocaine; Myocardial Infarction; Procainamide; Quinidine; Verapamil; Wolff-Parkinson-White Syndrome | 1981 |
[Tachycardias: considerations in childhood in the 90s].
Topics: Adenosine; Adolescent; Adult; Amiodarone; Atrial Flutter; Child; Child, Preschool; Electrocardiography; Ergometry; Flecainide; Heart; Heart Ventricles; Humans; Infant; Infant, Newborn; Lidocaine; Middle Aged; Propafenone; Sotalol; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Tachycardia, Ventricular | 1993 |
An overview of antiarrhythmic drug management of electrical storm.
Topics: Amiodarone; Anti-Arrhythmia Agents; Clinical Trials as Topic; Humans; Infusions, Intravenous; Lidocaine; Tachycardia, Ventricular; Ventricular Fibrillation | 1996 |
Advanced cardiac life support antiarrhythmic drugs.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Bretylium Compounds; Cardiopulmonary Resuscitation; Clinical Trials as Topic; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Heart Arrest; Humans; Lidocaine; Life Support Care; Magnesium; Male; Procainamide; Treatment Outcome | 2002 |
Strategies for reversing shock-resistant ventricular fibrillation.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Cardiopulmonary Resuscitation; Electric Countershock; Heart Arrest; Hemodynamics; Humans; Lidocaine; Magnesium; Procainamide; Vasoconstrictor Agents; Vasopressins; Ventricular Fibrillation | 2003 |
Cardiopulmonary Resuscitation Guidelines 2000 update: what's happened since?
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Electric Countershock; Emergency Medical Services; Heart Arrest; Humans; Hypothermia, Induced; Lidocaine; Practice Guidelines as Topic; Public Health; Pulse; Ventricular Fibrillation | 2003 |
Arrhythmias in the intensive care patient.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Critical Care; Defibrillators, Implantable; Electric Countershock; Electrocardiography; Hemodynamics; Humans; Lidocaine; Sotalol; Tachycardia; Tachycardia, Ventricular | 2003 |
[Cardiopulmonary resuscitation. Simpler is more effective: the current guidelines].
Topics: Adult; Advanced Cardiac Life Support; Aged; Algorithms; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cardiopulmonary Resuscitation; Child; Child, Preschool; Defibrillators, Implantable; Electric Countershock; Emergencies; Female; First Aid; Heart Massage; Humans; Intubation, Intratracheal; Lidocaine; Male; Practice Guidelines as Topic; Prognosis; Time Factors; Vasodilator Agents; Vasopressins | 2003 |
Ventricular tachyarrhythmias (out of hospital cardiac arrests).
Topics: Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Electric Countershock; Humans; Lidocaine; Tachycardia, Ventricular | 2006 |
Drug administration in animal studies of cardiac arrest does not reflect human clinical experience.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Clinical Trials as Topic; Disease Models, Animal; Drug Administration Schedule; Epinephrine; Heart Arrest; Humans; Lidocaine; Life Support Care; Magnesium Sulfate; Regression Analysis; Sodium Bicarbonate; Time Factors; Vasoconstrictor Agents; Vasopressins | 2007 |
[Arrhythmias during pregnancy].
Topics: Adenosine; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Defibrillators, Implantable; Electric Countershock; Female; Humans; Lidocaine; Pregnancy; Pregnancy Complications, Cardiovascular; Procainamide | 2008 |
Should amiodarone or lidocaine be given to patients who arrest after cardiac surgery and fail to cardiovert from ventricular fibrillation?
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Benchmarking; Cardiac Surgical Procedures; Cardiopulmonary Resuscitation; Electric Countershock; Evidence-Based Medicine; Heart Arrest; Humans; Injections, Intravenous; Lidocaine; Patient Selection; Practice Guidelines as Topic; Reoperation; Sternum; Treatment Failure; Treatment Outcome; Ventricular Fibrillation | 2008 |
Ventricular tachyarrhythmias (out-of-hospital cardiac arrests).
Topics: Amiodarone; Death, Sudden, Cardiac; Electric Countershock; Humans; Hypothermia, Induced; Lidocaine; Out-of-Hospital Cardiac Arrest; Ventricular Fibrillation | 2010 |
The "Code Drugs in Cardiac Arrest"--the use of cardioactive medications in cardiac arrest resuscitation.
Topics: Advanced Cardiac Life Support; Amiodarone; Atropine; Cardiotonic Agents; Epinephrine; Heart Arrest; Humans; Lidocaine; Practice Guidelines as Topic; Resuscitation; Vasopressins | 2012 |
Amiodarone supplants lidocaine in ACLS and CPR protocols.
Topics: Action Potentials; Advanced Cardiac Life Support; Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Cardiopulmonary Resuscitation; Clinical Trials as Topic; Death, Sudden, Cardiac; Heart Arrest; Humans; Lidocaine; Randomized Controlled Trials as Topic; Tachycardia, Ventricular; Thoracic Surgery | 2011 |
Amiodarone or lidocaine for cardiac arrest: A systematic review and meta-analysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Hospitalization; Humans; Lidocaine; Long Term Adverse Effects; Out-of-Hospital Cardiac Arrest; Survival Analysis | 2016 |
Best Clinical Practice: Emergency Medicine Management of Stable Monomorphic Ventricular Tachycardia.
Topics: Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Electrocardiography; Emergency Service, Hospital; Evidence-Based Medicine; Humans; Lidocaine; Procainamide; Pyrimidinones; Review Literature as Topic; Sotalol; Tachycardia, Ventricular | 2017 |
Amiodarone Versus Lidocaine for Pediatric Cardiac Arrest Due to Ventricular Arrhythmias: A Systematic Review.
Topics: Amiodarone; Anti-Arrhythmia Agents; Child; Combined Modality Therapy; Electric Countershock; Heart Arrest; Humans; Lidocaine; Pediatrics; Resuscitation; Treatment Outcome; Ventricular Fibrillation | 2017 |
Antiarrhythmic drugs for out-of-hospital cardiac arrest with refractory ventricular fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Emergency Medical Services; Humans; Intensive Care Units; Lidocaine; Out-of-Hospital Cardiac Arrest; Placebos; Pyrimidinones; Ventricular Fibrillation | 2017 |
Comparative effectiveness of antiarrhythmics for out-of-hospital cardiac arrest: A systematic review and network meta-analysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Humans; Lidocaine; Network Meta-Analysis; Out-of-Hospital Cardiac Arrest; Randomized Controlled Trials as Topic | 2017 |
Antiarrhythmic drug therapy during cardiopulmonary resuscitation: should we use it?
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiopulmonary Resuscitation; Female; Humans; Lidocaine; Male; Middle Aged; Out-of-Hospital Cardiac Arrest; Practice Guidelines as Topic; Survival Rate; Tachycardia, Ventricular | 2018 |
Effectiveness of antiarrhythmic drugs for shockable cardiac arrest: A systematic review.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Child; Female; Humans; Lidocaine; Male; Observational Studies as Topic; Out-of-Hospital Cardiac Arrest; Randomized Controlled Trials as Topic; Treatment Outcome | 2018 |
Effect of amiodarone and lidocaine on shock-refractory cardiac arrest: a systematic review and meta-analysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Cross-Sectional Studies; Humans; Lidocaine; Out-of-Hospital Cardiac Arrest | 2020 |
Amiodarone and/or lidocaine for cardiac arrest: A Bayesian network meta-analysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bayes Theorem; Heart Arrest; Humans; Lidocaine; Network Meta-Analysis; Survival Analysis | 2020 |
Comparison the efficacy of amiodarone and lidocaine for cardiac arrest: A network meta-analysis.
Topics: Amiodarone; Anti-Arrhythmia Agents; Heart Arrest; Humans; Lidocaine; Network Meta-Analysis | 2023 |
18 trial(s) available for amiodarone and lidocaine
| Article | Year |
|---|---|
[Intravenous administration of lidocaine and amiodarone in patients with acute myocardial infarction].
Topics: Amiodarone; Arrhythmias, Cardiac; Benzofurans; Female; Humans; Injections, Intravenous; Lidocaine; Male; Middle Aged; Myocardial Infarction | 1985 |
Selection of an antiarrhythmic drug for a sudden-death-prevention trial.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bretylium Compounds; Clinical Trials as Topic; Death, Sudden; Encainide; Flecainide; Humans; Kinetics; Lidocaine; Mexiletine; Moricizine; Morpholines; Phenothiazines; Piperidines; Tocainide; Verapamil | 1982 |
Interaction between amiodarone and lidocaine.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Blood Proteins; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Drug Interactions; Drug Therapy, Combination; Female; Humans; In Vitro Techniques; Kinetics; Lidocaine; Male; Microsomes, Liver; Middle Aged; Mixed Function Oxygenases; Protein Binding | 1996 |
Amiodarone as compared with lidocaine for shock-resistant ventricular fibrillation.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Combined Modality Therapy; Double-Blind Method; Electric Countershock; Emergency Medical Services; Female; Heart Arrest; Hospitalization; Humans; Infusions, Intravenous; Lidocaine; Logistic Models; Male; Middle Aged; Recurrence; Survival Rate; Time Factors; Ventricular Fibrillation | 2002 |
Intravenous lidocaine versus intravenous amiodarone (in a new aqueous formulation) for incessant ventricular tachycardia.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Blood Pressure; Double-Blind Method; Electric Countershock; Electrocardiography; Female; Humans; Infusions, Intravenous; Lidocaine; Male; Middle Aged; Tachycardia, Ventricular; Treatment Failure | 2002 |
Antiarrhythmic effect of magnesium sulfate after open heart surgery: effect of blood levels.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Surgical Procedures; Female; Humans; Lidocaine; Magnesium; Magnesium Sulfate; Male; Middle Aged; Treatment Outcome | 2003 |
Shock on T versus direct current voltage for induction of ventricular fibrillation: a randomized prospective comparison.
Topics: Amiodarone; Defibrillators, Implantable; Digoxin; Electric Countershock; Female; Humans; Lidocaine; Male; Metoprolol; Middle Aged; Prospective Studies; Ventricular Fibrillation | 2004 |
Lack of a hypotensive effect with rapid administration of a new aqueous formulation of intravenous amiodarone.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Hypotension; Infusions, Intravenous; Lidocaine; Male; Middle Aged; Pharmaceutical Solutions; Prospective Studies; Time Factors; Vasodilator Agents | 2004 |
Effects of intravenous nifekalant as a lifesaving drug for severe ventricular tachyarrhythmias complicating acute coronary syndrome.
Topics: Acute Coronary Syndrome; Aged; Amiodarone; Anti-Arrhythmia Agents; Blood Pressure; Electrocardiography; Emergency Medical Services; Female; Heart Rate; Humans; Infusions, Intravenous; Injections, Intravenous; Lidocaine; Male; Middle Aged; Pyrimidinones; Tachycardia, Ventricular; Torsades de Pointes; Ventricular Fibrillation | 2009 |
Prophylactic amiodarone versus lidocaine for prevention of reperfusion ventricular fibrillation after release of aortic cross-clamp.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Clinical Protocols; Coronary Artery Bypass; Female; Humans; Lidocaine; Male; Middle Aged; Myocardial Reperfusion; Treatment Outcome; Ventricular Fibrillation | 2009 |
Amiodarone versus lidocaine and placebo for the prevention of ventricular fibrillation after aortic crossclamping: a randomized, double-blind, placebo-controlled trial.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Aorta; Cardiac Surgical Procedures; Chi-Square Distribution; Constriction; Double-Blind Method; Electric Countershock; Female; Humans; Incidence; Lidocaine; Logistic Models; Male; Middle Aged; Minnesota; Multivariate Analysis; Odds Ratio; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; Ventricular Fibrillation | 2012 |
Resuscitation Outcomes Consortium-Amiodarone, Lidocaine or Placebo Study (ROC-ALPS): Rationale and methodology behind an out-of-hospital cardiac arrest antiarrhythmic drug trial.
Topics: Adolescent; Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Emergency Medical Services; Female; Follow-Up Studies; Heart Rate; Humans; Lidocaine; Male; North America; Out-of-Hospital Cardiac Arrest; Prospective Studies; Treatment Outcome; Ventricular Fibrillation; Young Adult | 2014 |
The effect of lidocaine and amiodarone on prevention of ventricular fibrillation in patients undergoing coronary artery bypass grafting.
Topics: Amiodarone; Anti-Arrhythmia Agents; Coronary Artery Bypass; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Lidocaine; Male; Middle Aged; Premedication; Prospective Studies; Treatment Outcome; Ventricular Fibrillation | 2014 |
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.
Topics: Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Central Nervous System Diseases; Combined Modality Therapy; Double-Blind Method; Electric Countershock; Emergency Medical Services; Female; Humans; Intention to Treat Analysis; Lidocaine; Male; Middle Aged; Out-of-Hospital Cardiac Arrest; Patient Discharge; Survival Rate; Tachycardia, Ventricular; Ventricular Fibrillation | 2016 |
Effects of intra-resuscitation antiarrhythmic administration on rearrest occurrence and intra-resuscitation ECG characteristics in the ROC ALPS trial.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Canada; Cardiopulmonary Resuscitation; Electrocardiography; Female; Follow-Up Studies; Humans; Lidocaine; Male; Middle Aged; Out-of-Hospital Cardiac Arrest; Retrospective Studies; Survival Rate; United States; Ventricular Fibrillation | 2018 |
Survival After Intravenous Versus Intraosseous Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Shock-Refractory Cardiac Arrest.
Topics: Administration, Intravenous; Aged; Amiodarone; Disease-Free Survival; Double-Blind Method; Female; Humans; Infusions, Intraosseous; Lidocaine; Male; Middle Aged; Out-of-Hospital Cardiac Arrest; Survival Rate | 2020 |
Effect of Time to Treatment With Antiarrhythmic Drugs on Return of Spontaneous Circulation in Shock-Refractory Out-of-Hospital Cardiac Arrest.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Humans; Lidocaine; Out-of-Hospital Cardiac Arrest; Return of Spontaneous Circulation; Time-to-Treatment; Ventricular Fibrillation | 2022 |
Survival by time-to-administration of amiodarone, lidocaine, or placebo in shock-refractory out-of-hospital cardiac arrest.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Emergency Medical Services; Hospitalization; Humans; Lidocaine; Out-of-Hospital Cardiac Arrest | 2023 |
160 other study(ies) available for amiodarone and lidocaine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Novel quinolizidinyl derivatives as antiarrhythmic agents.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Aorta, Thoracic; Electrocardiography; Female; Guinea Pigs; Heart Rate; In Vitro Techniques; Isometric Contraction; Lidocaine; Muscle, Smooth, Vascular; Myocardial Contraction; Procainamide; Quinidine; Quinolizines; Stimulation, Chemical; Structure-Activity Relationship; Vasodilation | 2007 |
Synthesis and biological studies of novel 2-aminoalkylethers as potential antiarrhythmic agents for the conversion of atrial fibrillation.
Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Biological Availability; Cell Line; Crystallography, X-Ray; Cyclohexanes; Dogs; Electric Stimulation; Ethers; Female; Humans; Male; Mice; Molecular Structure; Myocardial Ischemia; Patch-Clamp Techniques; Potassium Channels, Voltage-Gated; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sodium Channels; Stereoisomerism; Structure-Activity Relationship | 2007 |
Identification of new functional inhibitors of acid sphingomyelinase using a structure-property-activity relation model.
Topics: Algorithms; Animals; Cell Line; Cell Line, Tumor; Chemical Phenomena; Chemistry, Physical; Enzyme Inhibitors; Humans; Hydrogen-Ion Concentration; Molecular Conformation; Quantitative Structure-Activity Relationship; Rats; Sphingomyelin Phosphodiesterase | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Novel quinolizidinyl derivatives as antiarrhythmic agents: 2. Further investigation.
Topics: Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Electric Stimulation; Guinea Pigs; Heart; Heart Rate; Ileum; In Vitro Techniques; Muscle, Smooth; Myocardial Contraction; Platelet Aggregation Inhibitors; Quinolizidines; Receptor, Muscarinic M2; Stereoisomerism; Structure-Activity Relationship; Vasodilator Agents | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Synthesis and toxicopharmacological evaluation of m-hydroxymexiletine, the first metabolite of mexiletine more potent than the parent compound on voltage-gated sodium channels.
Topics: Animals; Anti-Arrhythmia Agents; Aorta; Ataxia; ATP Binding Cassette Transporter, Subfamily B, Member 1; Blood-Brain Barrier; Caco-2 Cells; Guinea Pigs; Heart; Heart Rate; HEK293 Cells; Humans; Ion Channel Gating; Mexiletine; Mice; NAV1.5 Voltage-Gated Sodium Channel; Permeability; Sodium Channels; Stereoisomerism; Vasodilator Agents | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
[Drug therapy of tachyarrhythmias (author's transl)].
Topics: Action Potentials; Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Calcium; Disopyramide; Electrophysiology; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Phenytoin; Procainamide; Quinidine; Tachycardia; Verapamil | 1978 |
Newer antiarrhythmic drugs.
Topics: Administration, Oral; Adult; Amiodarone; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Child; Edrophonium; Electrophysiology; Heart Conduction System; Heart Ventricles; Humans; Injections, Intravenous; Lidocaine; Mexiletine; Recurrence; Tachycardia; Tocainide; Verapamil; Wolff-Parkinson-White Syndrome | 1978 |
[Prolongation of the effective refractory period on isolated guinea pig atria by some anti-arrhythmia agents: relevance in a comparison of their potentialities].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Function; Dose-Response Relationship, Drug; Guinea Pigs; Heart Atria; Lidocaine; Myocardial Contraction; Nifedipine; Verapamil | 1979 |
Antiarrhythmic drugs: clinical pharmacology and therapeutic uses.
Topics: Acebutolol; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Bretylium Compounds; Digitalis Glycosides; Disopyramide; Humans; Kinetics; Lidocaine; Mexiletine; Oxytocin; Phenytoin; Procainamide; Propranolol; Quinidine; Verapamil | 1978 |
New antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Humans; Lidocaine; Mexiletine; Papaverine; Phenothiazines | 1978 |
Electrophysiologic and pharmacologic studies in a patient with acute myocardial infarction complicated by intraventricular and atrioventricular block.
Topics: Amiodarone; Bundle-Branch Block; Electrocardiography; Electrophysiology; Heart Block; Heart Conduction System; Humans; Isoproterenol; Lidocaine; Male; Middle Aged; Myocardial Infarction; Strophanthins | 1975 |
Antiarrhythmic and electrophysiological effects of amiodarone, lignocaine, and penticainide in anaesthetised rats.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Coronary Vessels; Dose-Response Relationship, Drug; Electrocardiography; Heart Rate; Lidocaine; Male; Propylamines; Pyridines; Rats; Rats, Sprague-Dawley; Reaction Time | 1992 |
Drug treatment of arrhythmias during cardiopulmonary resuscitation. A statement for the Advanced Life Support Working Party of the European Resuscitation Council.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Atropine; Bretylium Compounds; Calcium; Cardiopulmonary Resuscitation; Combined Modality Therapy; Electric Countershock; Humans; Lidocaine; Magnesium; Ventricular Fibrillation | 1992 |
Block of cardiac sodium channels by amiodarone studied by using Vmax of action potential in single ventricular myocytes.
Topics: Action Potentials; Amiodarone; Animals; Guinea Pigs; Heart; In Vitro Techniques; Lidocaine; Myocardium; Sodium Channels | 1991 |
Effect of antiarrhythmic drugs on choline uptake in cardiac cells in culture.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cells, Cultured; Chick Embryo; Choline; Dose-Response Relationship, Drug; Encainide; Flecainide; Heart; Lidocaine; Myocardium; Propafenone; Tocainide | 1992 |
Stabilization of cardiac rhythm in subsequently fatal ventricular tachycardia and fibrillation by calcitonin gene-related peptide.
Topics: Amiodarone; Calcitonin Gene-Related Peptide; Electric Countershock; Electrocardiography, Ambulatory; Humans; Lidocaine; Male; Middle Aged; Myocardial Infarction; Tachycardia; Ventricular Fibrillation | 1992 |
Comparison of the electrophysiological effect of amiodarone, lidocaine and quinidine on rat ventricular cells.
Topics: Action Potentials; Amiodarone; Animals; Calcium; Cnidarian Venoms; Ion Channel Gating; Ion Channels; Lidocaine; Potassium; Quinidine; Rats; Sodium; Ventricular Function, Left | 1990 |
Relationship between Vmax and conduction velocity in uniform anisotropic canine ventricular muscle: differences between the effects of lidocaine and amiodarone.
Topics: Action Potentials; Amiodarone; Animals; Dogs; Heart; Heart Conduction System; Heart Ventricles; In Vitro Techniques; Kinetics; Lidocaine; Microelectrodes; Potassium Chloride; Regression Analysis | 1990 |
Effects of hyperkalemia, acidosis, and hypoxia on the depression of maximum rate of depolarization by class I antiarrhythmic drugs in guinea pig myocardium: differential actions of class Ib and Ic agents.
Topics: Acidosis; Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Electric Stimulation; Electrophysiology; Encainide; Female; Guinea Pigs; Heart; Hyperkalemia; Hypoxia; In Vitro Techniques; Lidocaine; Male; Microelectrodes | 1991 |
Selective depression of maximum rate of depolarization of guinea-pig ventricular action potentials by amiodarone and lignocaine in simulated ischaemia: comparison with encainide.
Topics: Action Potentials; Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Coronary Disease; Encainide; Guinea Pigs; Heart; Heart Ventricles; Kinetics; Lidocaine; Myocardium; Sodium Channels; Stimulation, Chemical | 1990 |
[Acute myocardial uptake of lidocaine, mexiletine and amiodarone].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiac Catheterization; Coronary Disease; Humans; Injections, Intravenous; Lidocaine; Mexiletine; Myocardium; Time Factors | 1990 |
Interventional treatment for ventricular arrhythmias: the initial South Carolina case.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Coronary Disease; Drug Administration Schedule; Electric Countershock; Heart Ventricles; Humans; Lidocaine; Male; Pacemaker, Artificial | 1990 |
Antiarrhythmic drugs. Clinical pharmacology of the old and the new agents.
Topics: Acecainide; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Death, Sudden; Delayed-Action Preparations; Disopyramide; Heart Arrest; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Procainamide; Resuscitation; Tocainide | 1985 |
Comparative effects of tetrodotoxin, lidocaine, and amiodarone on Vmax in guinea pig cardiac Purkinje and papillary muscle fibers.
Topics: Action Potentials; Amiodarone; Animals; Electric Stimulation; Guinea Pigs; Heart; Heart Conduction System; In Vitro Techniques; Kinetics; Lidocaine; Myocardial Contraction; Papillary Muscles; Purkinje Fibers; Tetrodotoxin | 1989 |
[Torsade de pointes following intravenous infusion of amiodarone].
Topics: Aged; Amiodarone; Electrocardiography; Female; Humans; Infusions, Intravenous; Lidocaine; Tachycardia | 1989 |
[Cytotoxic effects of changrolin, lidocaine and amiodarone on ultrastructure of cultured rat beating cardiac myocytes].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cells, Cultured; Lidocaine; Myocardium; Quinazolines; Rats | 1989 |
[Cytotoxic effects of changrolin, lidocaine and amiodarone on cultured beating rat heart cells].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Aspartate Aminotransferases; Cells, Cultured; Lidocaine; Myocardium; Quinazolines; Rats; Rats, Inbred Strains | 1987 |
Orthostatic hypotension: clinical spectrum and approach to treatment.
Topics: Adult; Aged; Amiodarone; Disopyramide; Female; Flecainide; Humans; Hypotension, Orthostatic; Lidocaine; Male; Middle Aged; Piperidines; Procainamide; Quinidine; Sympathomimetics; Tocainide | 1986 |
Second generation antiarrhythmic agents: have we reached antiarrhythmic Nirvana?
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Tocainide | 1987 |
[Hyperkinetic ventricular arrhythmias in acute myocardial infarction: different etiopathogenetic mechanisms?].
Topics: Aged; Amiodarone; Electric Countershock; Electrocardiography; Female; Humans; Lidocaine; Male; Middle Aged; Myocardial Infarction; Prognosis; Ventricular Fibrillation | 1987 |
An experimental approach to the choice of antiarrhythmic therapy.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Coronary Disease; Diltiazem; Lidocaine; Mexiletine; Nifedipine; Phenoxybenzamine; Prazosin; Propafenone; Propiophenones; Propranolol; Stellate Ganglion; Verapamil | 1986 |
[Anti-arrhythmia agents (II): Mexiletine, aprindine, tocainide and amiodarone].
Topics: Action Potentials; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Humans; Lidocaine; Mexiletine; Tocainide | 1985 |
An unusual ventricular tachycardia responsive to verapamil.
Topics: Adult; Amiodarone; Bundle-Branch Block; Electrocardiography; Heart Ventricles; Humans; Lidocaine; Male; Tachycardia; Verapamil | 1986 |
The effect of antiarrhythmic drugs on life-threatening arrhythmias induced by the interaction between acute myocardial ischemia and sympathetic hyperactivity.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cats; Coronary Disease; Disease Models, Animal; Electrocardiography; Hemodynamics; Lidocaine; Mexiletine; Prazosin; Propranolol; Stellate Ganglion | 1985 |
Rate-dependent effects of intravenous lidocaine, procainamide and amiodarone on intraventricular conduction.
Topics: Adult; Aged; Amiodarone; Benzofurans; Electrocardiography; Female; Heart Conduction System; Heart Ventricles; Humans; Injections, Intravenous; Lidocaine; Male; Middle Aged; Procainamide; Time Factors | 1985 |
Effect of amiodarone on the pharmacokinetics of phenytoin, quinidine, and lidocaine in the rat.
Topics: Amiodarone; Animals; Benzofurans; Half-Life; Kinetics; Lidocaine; Liver; Male; Phenytoin; Quinidine; Rats; Rats, Inbred Strains | 1985 |
New drugs in the management of ventricular arrhythmias.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bretylium Compounds; Drug Interactions; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Propafenone; Propiophenones; Tocainide | 1984 |
Drugs and the heart. IV. Antiarrhythmic agents.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Bretylium Compounds; Digoxin; Disopyramide; Heart Conduction System; Hemodynamics; Humans; Lidocaine; Mexiletine; Procainamide; Quinidine; Verapamil | 1980 |
[Effects of anti-arrhythmia agents on heart rate. Significance and importance].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Disopyramide; Electrocardiography; Heart Conduction System; Heart Rate; Humans; Lidocaine; Propafenone; Propiophenones; Quinidine; Verapamil | 1981 |
Ventricular ectopy: etiology, evaluation, and therapy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Angina Pectoris; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Coronary Disease; Disopyramide; Echocardiography; Electric Stimulation; Humans; Ischemia; Lidocaine; Myocardial Infarction; Nitrates; Pacemaker, Artificial; Phenytoin; Procainamide; Radionuclide Imaging; Risk | 1982 |
Antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Disopyramide; Flecainide; Humans; Kinetics; Lidocaine; Mexiletine; Piperidines; Procainamide; Quinidine; Tocainide; Verapamil | 1983 |
New directions in antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Death, Sudden; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tachycardia; Tocainide; Verapamil | 1984 |
Antiarrhythmic therapy: new additions and future expectations.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Bretylium Tosylate; Disopyramide; Encainide; Humans; Lidocaine; Mexiletine; Tocainide; Verapamil | 1983 |
[Drug therapy of arrhythmia in coronary cardiopathy].
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Cardiac Complexes, Premature; Coronary Disease; Disopyramide; Electrocardiography; Humans; Lidocaine; Mexiletine; Piperidines; Propafenone; Propiophenones; Tachycardia; Tocainide | 1983 |
Rapid ventricular tachycardia due to His-Purkinje reentry.
Topics: Adult; Aged; Amiodarone; Bundle of His; Cardiac Pacing, Artificial; Electrocardiography; Heart Conduction System; Heart Ventricles; Humans; Lidocaine; Male; Myocardial Infarction; Procainamide; Purkinje Fibers; Tachycardia | 1984 |
[Cellular effects of anti-arrhythmia drugs. Their predictive value of therapeutic effects].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Catecholamines; Electrolytes; Heart Conduction System; Humans; Ion Channels; Lidocaine; Prognosis; Quinidine; Verapamil | 1981 |
Heart failure and hepatitis in a patient taking tocainide.
Topics: Amiodarone; Chemical and Drug Induced Liver Injury; Heart Failure; Humans; Lidocaine; Liver Function Tests; Male; Middle Aged; Tocainide | 1984 |
Nursing care for survivors of sudden cardiac death.
Topics: Adaptation, Psychological; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Heart Arrest; Heart Conduction System; Humans; Lidocaine; Mexiletine; Moricizine; Nursing Assessment; Phenothiazines; Tocainide | 1984 |
Worsening of arrhythmias during pharmacological treatment.
Topics: Adolescent; Adult; Aged; Ajmaline; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Child; Disopyramide; Female; Follow-Up Studies; Humans; Lidocaine; Male; Middle Aged; Nadolol; Piperidines; Propafenone; Propanolamines; Propiophenones; Tocainide | 1984 |
Drug therapy of cardiac arrhythmias.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Biological Availability; Encainide; Half-Life; Humans; Imidazoles; Intestinal Absorption; Kinetics; Lidocaine; Metabolic Clearance Rate; Mexiletine; Propafenone; Propiophenones; Protein Binding; Tachycardia; Tocainide | 1983 |
Clinical pharmacology of antiarrhythmic drugs: a review and overview, part II.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Disopyramide; Humans; Kinetics; Lidocaine; Mexiletine; Phenytoin; Procainamide; Propranolol; Tocainide | 1981 |
Advances in antiarrhythmic therapy. The role of newer antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Atrioventricular Node; Humans; Lidocaine; Mexiletine; Tocainide; Verapamil | 1982 |
Early reports on drug interactions.
Topics: Acetaminophen; Amiodarone; Apazone; Aspirin; Carbamazepine; Chlordiazepoxide; Cimetidine; Coumarins; Drug Interactions; Erythromycin; Ethanol; Furosemide; Gentamicins; Humans; Levodopa; Lidocaine; Phenytoin; Prenylamine; Quinidine | 1983 |
[Clinical pharmacology of anti-arrhythmia agents].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Humans; Lidocaine; Quinidine; Verapamil | 1983 |
Sinoatrial arrest due to lidocaine injection in sick sinus syndrome during amiodarone administration.
Topics: Amiodarone; Anesthesia, Local; Benzofurans; Cardiac Pacing, Artificial; Drug Interactions; Heart Arrest; Humans; Lidocaine; Male; Middle Aged; Sick Sinus Syndrome | 1982 |
Antiarrhythmic drugs.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Therapy, Combination; Humans; Lidocaine; Quinidine; Verapamil | 1981 |
Failure of antiarrhythmic drugs to prevent experimental reperfusion ventricular fibrillation.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Coronary Vessels; Dogs; Lidocaine; Ligation; Perfusion; Procainamide; Ventricular Fibrillation; Verapamil | 1981 |
Amiodarone is a dose-dependent noncompetitive and competitive inhibitor of T3 binding to thyroid hormone receptor subtype beta 1, whereas disopyramide, lignocaine, propafenone, metoprolol, dl-sotalol, and verapamil have no inhibitory effect.
Topics: Amiodarone; Anti-Arrhythmia Agents; Binding, Competitive; Disopyramide; Dose-Response Relationship, Drug; Humans; Lidocaine; Metoprolol; Propafenone; Receptors, Thyroid Hormone; Sotalol; Triiodothyronine; Verapamil | 1995 |
Neurotoxic action of some antiarrhythmic agents: comparative effects of propafenone, lidocaine and amiodarone on leech Retzius nerve cell.
Topics: Action Potentials; Amiodarone; Animals; Calcium; Ganglia, Invertebrate; Leeches; Lidocaine; Neurons; Patch-Clamp Techniques; Potassium; Potassium Channels; Propafenone | 1995 |
Amiodarone interaction with lidocaine.
Topics: Aged; Amiodarone; Drug Interactions; Humans; Infusions, Intravenous; Lidocaine; Male; Seizures | 1993 |
Sixty-six episodes of ventricular fibrillation within four hours: electrical stability restored by propafenone.
Topics: Amiodarone; Electric Countershock; Humans; Injections, Intravenous; Lidocaine; Male; Middle Aged; Myocardial Infarction; Propafenone; Recurrence; Time Factors; Ventricular Fibrillation | 1994 |
Anaesthesia for caesarean section in a patient receiving high dose amiodarone for fetal supraventricular tachycardia.
Topics: Adult; Amiodarone; Anesthesia, Epidural; Anesthesia, Obstetrical; Cesarean Section; Drug Interactions; Epinephrine; Female; Fentanyl; Fetal Diseases; Humans; Lidocaine; Pregnancy; Tachycardia, Supraventricular | 1994 |
Effects of amiodarone on refractory ventricular fibrillation in acute myocardial infarction: experimental study.
Topics: Amiodarone; Animals; Disease Models, Animal; Dogs; Electric Stimulation; Epinephrine; Female; Heart Conduction System; Heart Rate; Hemodynamics; Injections, Intravenous; Lidocaine; Male; Myocardial Infarction; Ventricular Fibrillation | 1994 |
Absence of pharmacokinetic interaction between amiodarone and lidocaine.
Topics: Aged; Amiodarone; Arrhythmias, Cardiac; Drug Interactions; Female; Humans; Lidocaine; Male; Middle Aged | 1994 |
Comparative efficacy of antiarrhythmic agents in preventing halothane-epinephrine arrhythmias in rats.
Topics: Amiodarone; Anesthesia, Inhalation; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Epinephrine; Flecainide; Halothane; Isoflurane; Lidocaine; Male; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Verapamil | 1993 |
Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs.
Topics: Amiodarone; Analysis of Variance; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Death, Sudden, Cardiac; Disease Models, Animal; Dronedarone; Female; Lidocaine; Male; Myocardial Ischemia; Sotalol; Stereoisomerism; Swine; Tachycardia, Ventricular; Ventricular Fibrillation | 1995 |
SR 33589, a new amiodarone-like agent: effect on ischemia- and reperfusion-induced arrhythmias in anesthetized rats.
Topics: Administration, Oral; Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzofurans; Chi-Square Distribution; Disease Models, Animal; Dose-Response Relationship, Drug; Dronedarone; Electrocardiography; Heart Block; Heart Rate; Injections, Intravenous; Lidocaine; Myocardial Reperfusion Injury; Random Allocation; Rats; Sotalol; Ventricular Fibrillation | 1995 |
[Etiologies of electric storm].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Bretylium Tosylate; Electric Countershock; Female; Hemodynamics; Humans; Lidocaine; Male; Middle Aged; Myocardial Infarction; Recurrence; Risk Factors; Tachycardia, Ventricular; Ventricular Fibrillation | 1997 |
Amiodarone inhibits production of tumor necrosis factor-alpha by human mononuclear cells: a possible mechanism for its effect in heart failure.
Topics: Amiodarone; Anti-Arrhythmia Agents; Disopyramide; Dose-Response Relationship, Drug; Heart Failure; Humans; Interleukin-1; Interleukin-6; Lidocaine; Monocytes; Osmolar Concentration; Quinidine; Tumor Necrosis Factor-alpha | 1997 |
Contrast-medium-induced ventricular fibrillation: arrhythmogenic mechanisms and the role of antiarrhythmic drugs in dogs.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Catheterization; Contrast Media; Coronary Angiography; Coronary Vessels; Dogs; Heart Conduction System; Injections, Intra-Arterial; Iohexol; Lidocaine; Premedication; Propanolamines; Propranolol; Ventricular Fibrillation; Verapamil | 1995 |
[Cardioprotective effects of the cyclic derivative of gamma-aminobutyric acid T3-146 during reperfusion].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Cats; Electrocardiography; gamma-Aminobutyric Acid; Lidocaine; Male; Myocardial Reperfusion Injury; Piracetam; Rats | 1997 |
[Correction of the cardiotoxic effect of the anti-arrhythmia agents with befol, sufan, and their combination].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Benzamides; Benzimidazoles; Cardiotonic Agents; Dibenzazepines; Drug Antagonism; Electrocardiography; Lidocaine; Male; Morpholines; Procainamide; Propranolol; Rats; Rats, Wistar; Succinates; Tryptophan; Verapamil | 1998 |
Ventricular arrhythmias and the use of antiarrhythmic drugs after cardiovascular surgery.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bretylium Compounds; Cardiovascular Surgical Procedures; Clinical Trials as Topic; Education, Medical, Continuing; Humans; Lidocaine; Postoperative Care; Procainamide; Tachycardia, Ventricular; Ventricular Fibrillation | 1998 |
Antiarrhythmic drugs in cardiac arrest resuscitation: intravenous amiodarone or intravenous lidocaine?
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Heart Arrest; Humans; Injections, Intravenous; Lidocaine | 2002 |
Amiodarone versus lidocaine for shock-resistant ventricular fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cost-Benefit Analysis; Heart Arrest; Hospitalization; Humans; Lidocaine; Survival Rate; Ventricular Fibrillation | 2002 |
Amiodarone versus lidocaine for shock-resistant ventricular fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Hospitalization; Humans; Lidocaine; Survival Rate; Time Factors; Ventricular Fibrillation | 2002 |
Amiodarone versus lidocaine for shock-resistant ventricular fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cost-Benefit Analysis; Hospitalization; Humans; Lidocaine; Survival Rate; Ventricular Fibrillation | 2002 |
Amiodarone versus lidocaine for shock-resistant ventricular fibrillation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Double-Blind Method; Excipients; Humans; Lidocaine; Placebos; Polysorbates; Ventricular Fibrillation | 2002 |
Intravenous administration of class I antiarrhythmic drug induced T wave alternans in an asymptomatic Brugada syndrome patient.
Topics: Amiodarone; Anti-Arrhythmia Agents; Bundle-Branch Block; Cardiac Pacing, Artificial; Electrocardiography; Electrophysiologic Techniques, Cardiac; Humans; Lidocaine; Male; Middle Aged; Signal Processing, Computer-Assisted; Syndrome; Ventricular Fibrillation | 2003 |
Electrical storm: case series and review of management.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Anti-Arrhythmia Agents; Anti-Obesity Agents; Brain Infarction; Clinical Trials as Topic; Death, Sudden, Cardiac; Echocardiography, Stress; Electric Countershock; Electrocardiography; Female; Humans; Injections, Intravenous; Lidocaine; Male; Middle Aged; Synephrine; Tachycardia, Ventricular; Ventricular Fibrillation | 2003 |
Verapamil sensitive idiopathic ventricular tachycardia in an infant.
Topics: Amiodarone; Anti-Arrhythmia Agents; Drug Resistance; Drug Therapy, Combination; Electrocardiography; Female; Humans; Infant; Lidocaine; Propranolol; Tachycardia, Ventricular; Verapamil | 2003 |
Amiodarone decreases heat, cold, and mechanical hyperalgesia in a rat model of neuropathic pain.
Topics: Amiodarone; Anesthetics, Local; Animals; Cold Temperature; Hot Temperature; Hyperalgesia; Injections, Intraperitoneal; Lidocaine; Male; Pain; Pain Measurement; Peripheral Nervous System Diseases; Physical Stimulation; Rats; Rats, Sprague-Dawley; Sciatic Neuropathy; Vasodilator Agents | 2004 |
Images in cardiovascular medicine. Fatal bidirectional and polymorphic ventricular tachycardia with terminal depolarization abnormality in a child.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Combined Modality Therapy; Electrocardiography; Fatal Outcome; Heart Arrest; Humans; Lidocaine; Male; Tachycardia, Ventricular | 2004 |
Salvage application of secondary blood cardioplegia in intractable ventricular fibrillation.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Blood Gas Analysis; Cardiopulmonary Bypass; Dose-Response Relationship, Drug; Electric Countershock; Electrocardiography; Female; Heart Arrest, Induced; Heart Septal Defects, Atrial; Heart Valve Prosthesis Implantation; Humans; Lidocaine; Magnesium Sulfate; Metoprolol; Mitral Valve; Postoperative Complications; Retreatment; Rheumatic Heart Disease; Ventricular Fibrillation | 2004 |
Compatibility of argatroban with selected cardiovascular agents.
Topics: Amiodarone; Anticoagulants; Arginine; Cardiovascular Agents; Drug Interactions; Drug Therapy, Combination; Fenoldopam; Furosemide; Humans; Infusions, Parenteral; Lidocaine; Milrinone; Natriuretic Peptide, Brain; Nitroglycerin; Nitroprusside; Pipecolic Acids; Sulfonamides; Vasopressins | 2004 |
Acute cardiodepressant effects induced by bolus intravenous administration of amiodarone in rabbits.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Blood Pressure; Cardiac Output; Female; Hypotension; Injections, Intravenous; Lidocaine; Male; Myocardial Contraction; Rabbits | 2005 |
Effect of lidocaine and amiodarone on transmural heterogeneity of ventricular repolarization in isolated rabbit hearts model of sustained global ischemia.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Electrocardiography; Female; Heart Ventricles; Lidocaine; Male; Myocardial Ischemia; Rabbits; Random Allocation; Tachycardia, Ventricular | 2005 |
Comparing intravenous amiodarone or lidocaine, or both, outcomes for inpatients with pulseless ventricular arrhythmias.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Drug Therapy, Combination; Female; Follow-Up Studies; Heart Arrest; Heart Rate; Humans; Injections, Intravenous; Inpatients; Lidocaine; Male; Middle Aged; Pulse; Retrospective Studies; Survival Rate; Tachycardia, Ventricular; Treatment Outcome | 2006 |
Effects of antiarrhythmic drugs on apoptotic pathways in H9c2 cardiac cells.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Apoptosis; Caspases; Cell Line; Clone Cells; Diploidy; DNA Fragmentation; Dose-Response Relationship, Drug; Lidocaine; Membrane Potentials; Mitochondrial Membranes; Propranolol; Pyrimidinones; Signal Transduction; Time Factors; Verapamil | 2006 |
Arrhythmogenic right ventricular dysplasia:clinical study.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Arrhythmogenic Right Ventricular Dysplasia; Catheter Ablation; Combined Modality Therapy; Diagnosis, Differential; Echocardiography; Electrocardiography; Female; Humans; Lidocaine; Magnetic Resonance Imaging; Metoprolol | 2007 |
Clinical and electrophysiological characteristics of patients having atrial flutter with 1:1 atrioventricular conduction.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Case-Control Studies; Catheter Ablation; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Flecainide; Heart Atria; Heart Conduction System; Heart Ventricles; Humans; Imidazoles; Lidocaine; Male; Middle Aged; Retrospective Studies; Risk Factors | 2008 |
Atrial-selective sodium channel block as a strategy for suppression of atrial fibrillation.
Topics: Acetanilides; Amiodarone; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Dogs; Electrophysiology; Heart Atria; Humans; Lidocaine; Piperazines; Propafenone; Ranolazine; Sodium Channel Blockers; Ventricular Function | 2008 |
Case files of the medical toxicology fellowship at the toxikon consortium in Chicago: cocaine-associated wide-complex dysrhythmias and cardiac arrest - treatment nuances and controversies.
Topics: Amiodarone; Anti-Arrhythmia Agents; Anticonvulsants; Antidotes; Arrhythmias, Cardiac; Charcoal; Cocaine; Electrocardiography; Emergency Medical Services; Female; Heart Arrest; Humans; Lidocaine; Lorazepam; Pulse; Seizures; Sodium Bicarbonate; Sympathomimetics; Tachycardia, Ventricular; Young Adult | 2008 |
Efficacy of amiodarone on refractory ventricular fibrillation resistant to lidocaine and cardioversion during weaning from cardiopulmonary bypass in aortic valve replacement for severe aortic stenosis with left ventricular hypertrophy.
Topics: Aged; Amiodarone; Anesthesia, General; Anti-Arrhythmia Agents; Aortic Valve; Aortic Valve Stenosis; Calcinosis; Cardiopulmonary Bypass; Drug Resistance; Electric Countershock; Female; Heart Valve Prosthesis Implantation; Humans; Hypertrophy, Left Ventricular; Intraoperative Complications; Lidocaine; Ventricular Fibrillation | 2010 |
Acute amiodarone promotes drift and early termination of spiral wave re-entry.
Topics: Action Potentials; Amiodarone; Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Disease Models, Animal; Electrophysiologic Techniques, Cardiac; Heart Conduction System; Heart Ventricles; Kinetics; Lidocaine; Perfusion; Rabbits; Tachycardia, Ventricular | 2010 |
Antiarrhythmic drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cohort Studies; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Lidocaine; Male; Middle Aged; Myocardial Infarction; Proportional Hazards Models; Retrospective Studies; Risk Assessment; Severity of Illness Index; Survival Analysis; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation | 2011 |
Drug therapy for sustained ventricular arrhythmias complicating acute myocardial infarction: What does the crystal ball tell you?
Topics: Amiodarone; Anti-Arrhythmia Agents; Critical Care; Critical Illness; Electrocardiography; Female; Humans; Lidocaine; Male; Myocardial Infarction; Prognosis; Risk Assessment; Severity of Illness Index; Survival Analysis; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation | 2011 |
Ranolazine reduces ventricular tachycardia burden and ICD shocks in patients with drug-refractory ICD shocks.
Topics: Acetanilides; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Cohort Studies; Defibrillators, Implantable; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Humans; Hypoglycemia; Lidocaine; Male; Mexiletine; Middle Aged; Myocardial Ischemia; Piperazines; Ranolazine; Sotalol; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome | 2011 |
A neonate with long QT syndrome, refractory ventricular arrhythmias, and lidocaine toxicity.
Topics: Amiodarone; Anesthetics, Local; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; DNA Mutational Analysis; Drug Interactions; Drug Substitution; Drug Therapy, Combination; Humans; Infant, Newborn; Lidocaine; Long QT Syndrome; Male; Propanolamines; Tachycardia, Ventricular | 2012 |
[Effect of anti-arrhythmia drugs on mouse arrhythmia induced by Bufonis Venenum].
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bufanolides; Electrocardiography; Female; Heart Rate; In Vitro Techniques; Lethal Dose 50; Lidocaine; Male; Mice; Phenytoin; Propranolol; Verapamil | 2011 |
Bidirectional ventricular tachycardia due to coronary allograft vasculopathy a unique presentation.
Topics: Amiodarone; Anti-Arrhythmia Agents; Coronary Artery Disease; Defibrillators, Implantable; Drug-Eluting Stents; Electrocardiography; Follow-Up Studies; Heart Transplantation; Humans; Lidocaine; Male; Middle Aged; Radiography; Tachycardia; Tachycardia, Ventricular; Transplantation, Homologous | 2012 |
Administration of amiodarone during resuscitation is associated with higher tumor necrosis factor-α levels in the early postarrest period in the swine model of ischemic ventricular fibrillation.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Coronary Vessels; Disease Models, Animal; Heart Arrest; Hemodynamics; Inflammation; Lidocaine; Male; Myocardial Ischemia; Random Amplified Polymorphic DNA Technique; Swine; Tumor Necrosis Factor-alpha; Ventricular Fibrillation | 2013 |
Prophylactic amiodarone and lidocaine improve survival in an ovine model of large size myocardial infarction.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Disease Models, Animal; Hemodynamics; Lidocaine; Mortality; Myocardial Infarction; Severity of Illness Index; Sheep, Domestic; Tachycardia, Ventricular; Ventricular Fibrillation | 2013 |
Outcomes associated with amiodarone and lidocaine in the treatment of in-hospital pediatric cardiac arrest with pulseless ventricular tachycardia or ventricular fibrillation.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Child; Child, Preschool; Cohort Studies; Heart Arrest; Hospitalization; Humans; Infant; Infant, Newborn; Lidocaine; Retrospective Studies; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation | 2014 |
Renewed impact of lidocaine on refractory ventricular arrhythmias in the amiodarone era.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Drug Therapy, Combination; Female; Humans; Lidocaine; Male; Middle Aged; Retrospective Studies; Stroke Volume; Tachycardia, Ventricular; Treatment Outcome; Ventricular Fibrillation | 2014 |
Letter to the editor regarding manuscript "resuscitation outcomes consortium-amiodarone, lidocaine or placebo: rationale and methodology behind out-of-hospital cardiac arrest antiarrhythmic drug trial".
Topics: Amiodarone; Cardiopulmonary Resuscitation; Female; Humans; Lidocaine; Male; Out-of-Hospital Cardiac Arrest; Ventricular Fibrillation | 2014 |
Regarding manuscript: "resuscitation outcomes consortium-amiodarone, lidocaine, or placebo study: rationale and methodology behind out-of-hospital cardiac arrest antiarrhythmic drug trial".
Topics: Amiodarone; Cardiopulmonary Resuscitation; Female; Humans; Lidocaine; Male; Out-of-Hospital Cardiac Arrest; Ventricular Fibrillation | 2014 |
Investigation of the antifibrillatory drug interactions between Amiodarone and Ibutilide in isolated, perfused Rabbit hearts.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Drug Interactions; Heart; Lidocaine; Perfusion; Propranolol; Rabbits; Reproducibility of Results; Sulfonamides; Ventricular Fibrillation | 2015 |
Out-of-Hospital Cardiac Arrest--Are Drugs Ever the Answer?
Topics: Amiodarone; Anti-Arrhythmia Agents; Female; Humans; Lidocaine; Male; Out-of-Hospital Cardiac Arrest | 2016 |
Lysosomotropic cationic drugs induce cytostatic and cytotoxic effects: Role of liposolubility and autophagic flux and antagonism by cholesterol ablation.
Topics: Amiodarone; Anticholesteremic Agents; Autophagy; beta-Cyclodextrins; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Chloroquine; Cholesterol; Cytostatic Agents; Cytotoxins; Human Umbilical Vein Endothelial Cells; Humans; Hydroxychloroquine; Lidocaine; Lovastatin; Lysosomes; Microtubule-Associated Proteins; Poly (ADP-Ribose) Polymerase-1; Procainamide; Quinacrine | 2016 |
Sex differences in the prehospital management of out-of-hospital cardiac arrest.
Topics: Aged; Aged, 80 and over; Amiodarone; Arrhythmias, Cardiac; Atropine; Cardiopulmonary Resuscitation; Databases, Factual; Emergency Medical Services; Epinephrine; Female; Humans; Lidocaine; Logistic Models; Male; Middle Aged; Multivariate Analysis; Out-of-Hospital Cardiac Arrest; Practice Guidelines as Topic; Retrospective Studies; Sex Factors; Time-to-Treatment | 2016 |
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Emergency Medical Services; Heart Arrest; Humans; Lidocaine; Out-of-Hospital Cardiac Arrest; Treatment Outcome; Ventricular Fibrillation | 2016 |
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Emergency Medical Services; Heart Arrest; Humans; Lidocaine; Out-of-Hospital Cardiac Arrest; Treatment Outcome; Ventricular Fibrillation | 2016 |
Amiodarone, Lidocaine, or Placebo in Out-of-Hospital Cardiac Arrest.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Emergency Medical Services; Heart Arrest; Humans; Lidocaine; Out-of-Hospital Cardiac Arrest; Treatment Outcome; Ventricular Fibrillation | 2016 |
Amiodarone Compared with Lidocaine for Out-Of-Hospital Cardiac Arrest with Refractory Ventricular Fibrillation on Hospital Arrival: a Nationwide Database Study.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Databases, Factual; Female; Hospital Mortality; Hospitalization; Humans; Japan; Lidocaine; Male; Middle Aged; Out-of-Hospital Cardiac Arrest; Ventricular Fibrillation | 2016 |
Acute hospital administration of amiodarone and/or lidocaine in shockable patients presenting with out-of-hospital cardiac arrest: A nationwide cohort study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Electric Countershock; Female; Humans; Lidocaine; Male; Middle Aged; Out-of-Hospital Cardiac Arrest; Retrospective Studies; Survival Rate; Taiwan | 2017 |
In Patients With Cardiac Arrest, Does Amiodarone or Lidocaine Increase Meaningful Survival?
Topics: Amiodarone; Anti-Arrhythmia Agents; Heart Arrest; Humans; Lidocaine; Ventricular Fibrillation | 2017 |
A Perfect Storm: Tyrosine Kinase Inhibitor-Associated Polymorphic Ventricular Tachycardia.
Topics: Adenine; Amiodarone; Anti-Arrhythmia Agents; Antineoplastic Agents; Cardiotonic Agents; Electric Countershock; Electrocardiography; Electrophysiology; Emergency Service, Hospital; Extracorporeal Membrane Oxygenation; Humans; Intensive Care Units; Intra-Aortic Balloon Pumping; Isoproterenol; Lidocaine; Magnesium; Male; Middle Aged; Piperidines; Pyrazoles; Pyrimidines; Respiration, Artificial; Syncope; Tachycardia, Ventricular; Torsades de Pointes; Waldenstrom Macroglobulinemia; Workforce | 2017 |
March 26th Question.
Topics: Ablation Techniques; Action Potentials; Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Drug Resistance; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Heart Rate; Heart Ventricles; Humans; Lidocaine; Predictive Value of Tests; Tachycardia, Ventricular | 2018 |
Trends Over Time in Drug Administration During Adult In-Hospital Cardiac Arrest.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atropine; Bicarbonates; Calcium; Epinephrine; Female; Glucose; Guideline Adherence; Heart Arrest; Hospitalization; Humans; Lidocaine; Logistic Models; Magnesium; Male; Middle Aged; Odds Ratio; Practice Guidelines as Topic; Practice Patterns, Physicians'; Vasoconstrictor Agents; Vasopressins | 2019 |
European Resuscitation Council Guidelines for Resuscitation: 2018 Update - Antiarrhythmic drugs for cardiac arrest.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Child; Electric Countershock; Europe; Heart Arrest; Humans; Lidocaine; Magnesium | 2019 |
2018 American Heart Association Focused Update on Advanced Cardiovascular Life Support Use of Antiarrhythmic Drugs During and Immediately After Cardiac Arrest: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Em
Topics: American Heart Association; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Emergency Medical Services; Heart Arrest; Humans; Lidocaine; Magnesium; Tachycardia, Ventricular; United States; Ventricular Fibrillation | 2018 |
2018 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations Summary.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Consensus; Emergency Medical Services; Humans; Lidocaine; Magnesium; Out-of-Hospital Cardiac Arrest | 2018 |
2018 American Heart Association Focused Update on Pediatric Advanced Life Support: An Update to the American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.
Topics: American Heart Association; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Child; Emergency Medical Services; Humans; Lidocaine; Out-of-Hospital Cardiac Arrest; Tachycardia, Ventricular; United States; Ventricular Fibrillation | 2018 |
Outcomes associated with amiodarone and lidocaine for the treatment of adult in-hospital cardiac arrest with shock-refractory pulseless ventricular tachyarrhythmia.
Topics: Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Electric Countershock; Female; Heart Arrest; Hospitalization; Humans; Lidocaine; Logistic Models; Male; Middle Aged; Multivariate Analysis; Retrospective Studies; Tachycardia, Ventricular; Taiwan; Treatment Outcome; Ventricular Fibrillation | 2020 |
Lidocaine versus amiodarone for pediatric in-hospital cardiac arrest: An observational study.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Child; Child, Preschool; Cohort Studies; Female; Humans; Infant; Lidocaine; Male | 2020 |
No shocking updates for the lidocaine vs amiodarone in pediatric pVT/VF story.
Topics: Amiodarone; Anti-Arrhythmia Agents; Child; Humans; Lidocaine; Ventricular Fibrillation | 2020 |
New Onset Recurrent Syncope Triggered by Fever.
Topics: Amiodarone; Coronary Angiography; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Female; Fever; Humans; Lidocaine; Middle Aged; Pharyngitis; Purkinje Fibers; Recurrence; Streptococcal Infections; Syncope; Tonsillitis; Torsades de Pointes; Ventricular Fibrillation; Ventricular Premature Complexes | 2020 |
Assessing the confidence in network meta-analysis results.
Topics: Amiodarone; Bayes Theorem; Heart Arrest; Humans; Lidocaine; Network Meta-Analysis | 2021 |
The authors respond: Assessing the confidence in network meta-analysis results.
Topics: Amiodarone; Bayes Theorem; Heart Arrest; Humans; Lidocaine; Network Meta-Analysis | 2021 |
Outcomes associated with lidocaine and amiodarone administration in pediatric in-hospital cardiac arrest.
Topics: Amiodarone; Anti-Arrhythmia Agents; Child; Heart Arrest; Hospitals; Humans; Lidocaine; Ventricular Fibrillation | 2021 |
Time to amiodarone administration and survival outcomes in refractory ventricular fibrillation.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Emergency Medical Services; Humans; Lidocaine; Out-of-Hospital Cardiac Arrest; Ventricular Fibrillation | 2021 |
Amiodarone or lidocaine, that is the question - Pharmacological therapy of refractory ventricular fibrillation associated with Brugada syndrome.
Topics: Amiodarone; Anti-Arrhythmia Agents; Brugada Syndrome; Humans; Lidocaine; Ventricular Fibrillation | 2021 |
Bayesian analysis of amiodarone or lidocaine versus placebo for out-of-hospital cardiac arrest.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Bayes Theorem; Humans; Lidocaine; Out-of-Hospital Cardiac Arrest; Randomized Controlled Trials as Topic; Ventricular Fibrillation | 2022 |
Time to Antiarrhythmic and Association with Return of Spontaneous Circulation in the United States.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Emergency Medical Services; Humans; Lidocaine; Out-of-Hospital Cardiac Arrest; Return of Spontaneous Circulation; United States | 2023 |
Procainamide for shockable rhythm cardiac arrest in the Resuscitation Outcome Consortium.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Emergency Medical Services; Humans; Lidocaine; Out-of-Hospital Cardiac Arrest; Procainamide; Retrospective Studies | 2022 |
Comparative Effectiveness of Amiodarone and Lidocaine for the Treatment of In-Hospital Cardiac Arrest.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Hospitals; Humans; Lidocaine; Out-of-Hospital Cardiac Arrest; Retrospective Studies; Ventricular Fibrillation | 2023 |
Comparison of the effects of lidocaine and amiodarone for out-of-hospital cardiac arrest patients with shockable rhythms: a retrospective observational study from a multicenter registry.
Topics: Adult; Amiodarone; Cardiopulmonary Resuscitation; Electric Countershock; Emergency Medical Services; Humans; Lidocaine; Out-of-Hospital Cardiac Arrest; Registries; Tachycardia, Ventricular; Ventricular Fibrillation | 2022 |
Evaluation of the effectiveness of potassium chloride in the management of out-of hospital cardiac arrest by refractory ventricular fibrillation: Study protocol of the POTACREH study.
Topics: Amiodarone; Cardiopulmonary Resuscitation; Clinical Trials, Phase II as Topic; Electric Countershock; Emergency Medical Services; Hospitals; Humans; Lidocaine; Multicenter Studies as Topic; Out-of-Hospital Cardiac Arrest; Potassium Chloride; Prospective Studies; Ventricular Fibrillation | 2023 |
Regarding the Comparative Effectiveness of Lidocaine and Amiodarone for Treatment of In-Hospital Cardiac Arrest.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Heart Arrest; Hospitals; Humans; Lidocaine; Ventricular Fibrillation | 2023 |
The Effect of Time to Treatment With Antiarrhythmic Drugs on Survival and Neurological Outcomes in Shock Refractory Out-of-Hospital Cardiac Arrest.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiopulmonary Resuscitation; Humans; Lidocaine; Out-of-Hospital Cardiac Arrest; Time-to-Treatment | 2023 |
Stable Ventricular Fibrillation: A Paradigm Rather Than Septal Shift?
Topics: Amiodarone; Arrhythmias, Cardiac; Humans; Lidocaine; Tachycardia, Ventricular; Ventricular Fibrillation | 2023 |